Shaon is a 41-year-old African American male with a history of hypertension and hypertriglyceridemia.

Current medications include: ezetimibe 10 mg daily, niacin SR 1,000 mg at bedtime and HCTZ/lisinopril 25/20 mg daily.

He complains of lack of energy, core weight gain, and a decrease in erections.

Labs reveal: testosterone 180 ng/dL (193-836 ng/dL) with normal TSH/thyroxine, FSH, LH, and PSA.

1. Is this patient a candidate for testosterone therapy? Why or why not?
2. Which, if any, of his medications are contributing to his symptoms?
3. Discuss the medications that you will prescribe and/or recommend.
4. Include patient education for the visit, as well.

Include diagnostics and work-up, as deemed appropriate for the clinical guidelines

ANSWER

Is this patient a candidate for testosterone therapy? Why or why not?

Based on the provided information, this patient may be a candidate for testosterone therapy due to his low testosterone levels (180 ng/dL), which fall below the normal reference range (193-836 ng/dL). However, the decision to initiate testosterone therapy should consider various factors, including the severity of his symptoms, underlying causes of low testosterone, and potential risks and benefits of treatment.

Which, if any, of his medications are contributing to his symptoms?

Among the patient’s current medications, niacin (nicotinic acid) may contribute to his symptoms. Niacin is known to have side effects, including fatigue, weight gain, and potential alterations in liver function. These side effects may impact the patient’s energy levels, weight, and overall well-being. However, further evaluation is necessary to determine if niacin is the primary contributor to his symptoms.

Discuss the medications that you will prescribe and/or recommend

1. Testosterone Replacement Therapy (TRT): Given the patient’s low testosterone levels and associated symptoms, testosterone replacement therapy may be considered. The choice of TRT modality (e.g., intramuscular injections, transdermal patches, or gels) should be individualized based on patient preferences, lifestyle, and potential contraindications.

2. Review and Adjust Current Medications:The patient’s niacin therapy should be reviewed and assessed for its necessity. If niacin is identified as a potential contributor to his symptoms, alternatives or dose adjustments may be considered, depending on his lipid profile.

3. Patient Education: The patient should receive education on the potential benefits and risks of testosterone therapy. This should include discussions about potential side effects, monitoring requirements, and expectations regarding symptom relief.

4. Monitoring: Regular follow-up visits and laboratory monitoring should be scheduled to assess the patient’s response to treatment and adjust therapy as needed.

Diagnostics and Work-up

1. Further Hormone Evaluation: Additional hormonal assessments, including free testosterone levels and sex hormone-binding globulin (SHBG), may provide a more comprehensive understanding of the patient’s hormonal status.

2. Lipid Profile: Given the patient’s hypertriglyceridemia, a thorough lipid profile should be obtained to assess lipid levels and determine the effectiveness of current lipid-lowering therapy.

3. Liver Function Tests: Since niacin can affect liver function, liver function tests (e.g., alanine transaminase, aspartate transaminase) should be monitored regularly.

4. Cardiovascular Risk Assessment: Considering the patient’s cardiovascular risk factors (hypertension, hypertriglyceridemia), an assessment of overall cardiovascular risk, including factors such as blood pressure, should be performed.

In summary, testosterone replacement therapy may be considered for this patient due to low testosterone levels and associated symptoms. However, a comprehensive evaluation of his medications, including niacin, is necessary to identify potential contributors to his symptoms. The choice of treatment should be individualized, and patient education and monitoring are essential components of his care.